• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子信号转导抑制因子 1 的激酶抑制区的环状模拟物:新型抗炎治疗的进展。

Cyclic mimetics of kinase-inhibitory region of Suppressors of Cytokine Signaling 1: Progress toward novel anti-inflammatory therapeutics.

机构信息

Department of Pharmacy - University of Naples "Federico II", 80134, Naples, Italy; Renal and Vascular Inflammation Group, Instituto de Investigacion Sanitaria-Fundacion Jimenez Diaz (IIS-FJD), Autonoma University of Madrid (UAM), 28040, Madrid, Spain.

Renal and Vascular Inflammation Group, Instituto de Investigacion Sanitaria-Fundacion Jimenez Diaz (IIS-FJD), Autonoma University of Madrid (UAM), 28040, Madrid, Spain; Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), 28040, Madrid, Spain.

出版信息

Eur J Med Chem. 2021 Oct 5;221:113547. doi: 10.1016/j.ejmech.2021.113547. Epub 2021 May 14.

DOI:10.1016/j.ejmech.2021.113547
PMID:34023736
Abstract

Herein we investigated the structural and cellular effects ensuing from the cyclization of a potent inhibitor of JAK2 as mimetic of SOCS1 protein, named PS5. The introduction of un-natural residues and a lactam internal bridge, within SOCS1-KIR motif, produced candidates that showed high affinity toward JAK2 catalytic domain. By combining CD, NMR and computational studies, we obtained valuable models of the interactions of two peptidomimetics of SOCS1 to deepen their functional behaviors. Notably, when assayed for their biological cell responses mimicking SOCS1 activity, the internal cyclic PS5 analogues demonstrated able to inhibit JAK-mediated tyrosine phosphorylation of STAT1 and to reduce cytokine-induced proinflammatory gene expression, oxidative stress generation and cell migration. The present study well inserts in the field of low-molecular-weight proteomimetics with improved longtime cellular effects and adds a new piece to the puzzled way for the conversion of bioactive peptides into drugs.

摘要

在此,我们研究了一种强效 JAK2 抑制剂 PS5 环化后产生的结构和细胞效应,该抑制剂模拟了 SOCS1 蛋白。在 SOCS1-KIR 基序内引入非天然残基和内酰胺桥,产生了对 JAK2 催化结构域具有高亲和力的候选物。通过结合 CD、NMR 和计算研究,我们获得了两种 SOCS1 肽模拟物相互作用的有价值模型,以深入了解它们的功能行为。值得注意的是,当检测它们模拟 SOCS1 活性的生物细胞反应时,内部环状 PS5 类似物能够抑制 JAK 介导的 STAT1 酪氨酸磷酸化,并降低细胞因子诱导的促炎基因表达、氧化应激产生和细胞迁移。本研究很好地插入了小分子蛋白质模拟物领域,具有改善的长时间细胞效应,并为将生物活性肽转化为药物的困惑途径增添了新的内容。

相似文献

1
Cyclic mimetics of kinase-inhibitory region of Suppressors of Cytokine Signaling 1: Progress toward novel anti-inflammatory therapeutics.细胞因子信号转导抑制因子 1 的激酶抑制区的环状模拟物:新型抗炎治疗的进展。
Eur J Med Chem. 2021 Oct 5;221:113547. doi: 10.1016/j.ejmech.2021.113547. Epub 2021 May 14.
2
Ad-hoc modifications of cyclic mimetics of SOCS1 protein: Structural and functional insights.SOCS1 蛋白的环状拟肽的即席修饰:结构和功能的见解。
Eur J Med Chem. 2022 Dec 5;243:114781. doi: 10.1016/j.ejmech.2022.114781. Epub 2022 Sep 19.
3
Antioxidant Effects of PS5, a Peptidomimetic of Suppressor of Cytokine Signaling 1, in Experimental Atherosclerosis.细胞因子信号转导抑制因子1的拟肽PS5在实验性动脉粥样硬化中的抗氧化作用
Antioxidants (Basel). 2020 Aug 14;9(8):754. doi: 10.3390/antiox9080754.
4
Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist.细胞因子信号转导抑制因子1(SOCS-1)激酶抑制区域和SOCS-1模拟物均与JAK2自身磷酸化位点结合:对SOCS-1拮抗剂开发的启示。
J Immunol. 2007 Apr 15;178(8):5058-68. doi: 10.4049/jimmunol.178.8.5058.
5
Structure-activity studies of peptidomimetics based on kinase-inhibitory region of suppressors of cytokine signaling 1.基于细胞因子信号转导抑制因子1激酶抑制区域的拟肽的构效关系研究
Biopolymers. 2017 Nov 20. doi: 10.1002/bip.23082.
6
New mimetic peptides of the kinase-inhibitory region (KIR) of SOCS1 through focused peptide libraries.通过聚焦肽文库发现 SOCS1 激酶抑制区(KIR)的新型模拟肽。
Biochem J. 2012 Apr 1;443(1):231-40. doi: 10.1042/BJ20111647.
7
SOCS1 Peptidomimetic Alleviates Glomerular Inflammation in MsPGN by Inhibiting Macrophage M1 Polarization.SOCS1拟肽通过抑制巨噬细胞M1极化减轻系膜增生性肾小球肾炎中的肾小球炎症。
Inflammation. 2023 Dec;46(6):2402-2414. doi: 10.1007/s10753-023-01886-3. Epub 2023 Aug 15.
8
Downregulated SOCS1 expression activates the JAK1/STAT1 pathway and promotes polarization of macrophages into M1 type.SOCS1 表达下调激活 JAK1/STAT1 通路,并促进巨噬细胞向 M1 型极化。
Mol Med Rep. 2017 Nov;16(5):6405-6411. doi: 10.3892/mmr.2017.7384. Epub 2017 Aug 29.
9
Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.细胞因子信号转导抑制因子 1 衍生肽抑制 Janus 激酶/信号转导和转录激活因子通路,改善糖尿病小鼠的炎症和动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1953-60. doi: 10.1161/ATVBAHA.114.304144. Epub 2014 Jul 10.
10
Therapeutical potential of a peptide mimicking the SOCS1 kinase inhibitory region in skin immune responses.模拟 SOCS1 激酶抑制区的肽在皮肤免疫反应中的治疗潜力。
Eur J Immunol. 2013 Jul;43(7):1883-95. doi: 10.1002/eji.201343370. Epub 2013 May 28.

引用本文的文献

1
Recent advances and future perspectives in small molecule JAK2 inhibitors.小分子JAK2抑制剂的最新进展与未来展望
Future Med Chem. 2025 May;17(10):1175-1191. doi: 10.1080/17568919.2025.2507564. Epub 2025 May 20.
2
Development of SOCS1 mimetics as novel approach to harmonize inflammation, oxidative stress, and fibrogenesis in metabolic dysfunction-associated steatotic liver disease.开发SOCS1模拟物作为协调代谢功能障碍相关脂肪性肝病中炎症、氧化应激和纤维化形成的新方法。
Redox Biol. 2025 Jul;84:103670. doi: 10.1016/j.redox.2025.103670. Epub 2025 May 11.
3
Peptide discovery across the spectrum of neuroinflammation; microglia and astrocyte phenotypical targeting, mediation, and mechanistic understanding.
神经炎症全谱中的肽发现;小胶质细胞和星形胶质细胞表型靶向、介导及机制理解。
Front Mol Neurosci. 2024 Nov 20;17:1443985. doi: 10.3389/fnmol.2024.1443985. eCollection 2024.
4
PEGylated SOCS3 Mimetics Encapsulated into PLGA-NPs as Selective Inhibitors of JAK/STAT Pathway in TNBC Cells.聚乙二醇化 SOCS3 模拟物包封于 PLGA-NPs 中,作为 TNBC 细胞中 JAK/STAT 通路的选择性抑制剂。
Int J Nanomedicine. 2024 Jul 18;19:7237-7251. doi: 10.2147/IJN.S441205. eCollection 2024.
5
Are peptidomimetics the compounds of choice for developing new modulators of the JAK-STAT pathway?肽模拟物是开发 JAK-STAT 通路新调节剂的首选化合物吗?
Front Immunol. 2024 Jun 24;15:1406886. doi: 10.3389/fimmu.2024.1406886. eCollection 2024.
6
SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation.SOCS1 和 SOCS3 作为与皮肤炎症和恶性转化相关的免疫反应中的关键检查点分子。
Front Immunol. 2024 Jun 21;15:1393799. doi: 10.3389/fimmu.2024.1393799. eCollection 2024.
7
Therapeutic peptides for coronary artery diseases: in silico methods and current perspectives.治疗冠状动脉疾病的治疗性肽:计算方法和当前观点。
Amino Acids. 2024 May 31;56(1):37. doi: 10.1007/s00726-024-03397-3.
8
Syringic acid demonstrates an anti-inflammatory effect via modulation of the NF-κB-iNOS-COX-2 and JAK-STAT signaling pathways in methyl cellosolve-induced hepato-testicular inflammation in rats.丁香酸通过调节大鼠甲基溶纤剂诱导的肝睾丸炎症中的NF-κB-iNOS-COX-2和JAK-STAT信号通路发挥抗炎作用。
Biochem Biophys Rep. 2023 May 5;34:101484. doi: 10.1016/j.bbrep.2023.101484. eCollection 2023 Jul.
9
Structure-Activity Relationship Investigations of Novel Constrained Chimeric Peptidomimetics of SOCS3 Protein Targeting JAK2.靶向JAK2的SOCS3蛋白新型受限嵌合肽模拟物的构效关系研究
Pharmaceuticals (Basel). 2022 Apr 9;15(4):458. doi: 10.3390/ph15040458.
10
Proteomimetics of Natural Regulators of JAK-STAT Pathway: Novel Therapeutic Perspectives.JAK-STAT 信号通路天然调节剂的蛋白质模拟物:新的治疗前景
Front Mol Biosci. 2022 Jan 3;8:792546. doi: 10.3389/fmolb.2021.792546. eCollection 2021.